Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer

Clinical Trials, Metastatic Castration Resistant Prostate Cancer (MCRPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05369000
Phase: clinical trials
Trial Summary: This is a phase 1/2a, first-in-human study to evaluate the safety and tolerability of LAVA-1207 in patients with therapy refractory metastatic castration resistant prosta – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Phase 1|Phase 2
Acronym:

Pin It on Pinterest